SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000947871-23-000626
Filing Date
2023-05-24
Accepted
2023-05-24 16:52:07
Documents
2
Group Members
ORBIMED CAPITAL GP V LLCORBIMED CAPITAL GP VII LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss2112018_sc13d.htm SC 13D 96701
2 JOINT FILING AGREEMENT ss2112018_ex9901.htm EX-99.1 6467
  Complete submission text file 0000947871-23-000626.txt   104704
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address AESCHENVORSTADT 36 BASEL V8 4051
Business Address AESCHENVORSTADT 36 BASEL V8 4051 41 61 551 30 30
VectivBio Holding AG (Subject) CIK: 0001836379 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92481 | Film No.: 23954863
SIC: 2836 Biological Products, (No Diagnostic Substances)